Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 41 citing articles:

The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 977
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
Factors Associated With Household Transmission of SARS-CoV-2
Zachary J. Madewell, Yang Yang, Ira M. Longini, et al.
JAMA Network Open (2021) Vol. 4, Iss. 8, pp. e2122240-e2122240
Open Access | Times Cited: 149
Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant
Charlotte B. Acharya, John Schrom, Anthea Mitchell, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 62
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
Katie L. Kunze, Patrick W. Johnson, Noud van Helmond, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 58
Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge
John Schrom, Carina Marquez, Genay Pilarowski, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 5, pp. 682-690
Open Access | Times Cited: 57
Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Incidence of the Presumptive B.1.427/B.1.429 Variant Among Healthcare Personnel at a Northern California Academic Medical Center
Karen B. Jacobson, Benjamin A. Pinsky, Maria E. Montez Rath, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 5, pp. 821-828
Open Access | Times Cited: 55
SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron
Matthew T. Laurie, Jamin Liu, Sara Sunshine, et al.
The Journal of Infectious Diseases (2022) Vol. 225, Iss. 11, pp. 1909-1914
Open Access | Times Cited: 44
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods
Carina Marquez, Andrew D. Kerkhoff, John Schrom, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2235844-e2235844
Open Access | Times Cited: 41
Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center
Karen B. Jacobson, Benjamin A. Pinsky, Maria E. Montez Rath, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 33
Online Phylogenetics with matOptimize Produces Equivalent Trees and is Dramatically More Efficient for Large SARS-CoV-2 Phylogenies than de novo and Maximum-Likelihood Implementations
Alexander Krämer, Bryan Thornlow, Cheng Ye, et al.
Systematic Biology (2023) Vol. 72, Iss. 5, pp. 1039-1051
Open Access | Times Cited: 15
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups When Infected with SARS-CoV-2 Delta Variant
Charlotte B. Acharya, John Schrom, Anthea Mitchell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 31
RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
Juan Shi, Jian Zheng, Xiujuan Zhang, et al.
Translational research (2022) Vol. 248, pp. 11-21
Open Access | Times Cited: 17
Comprehensive mapping of neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19
Using genomic epidemiology of SARS-CoV-2 to support contact tracing and public health surveillance in rural Humboldt County, California
Gunnar Stoddard, Allison Black, Patrick Ayscue, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Whole‐genome single molecule real‐time sequencing of SARS‐CoV‐2 Omicron
Florence Nicot, Pauline Trémeaux, Justine Latour, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 7
A systematic review comparing at-home diagnostic tests for SARS-CoV-2: Key points for pharmacy practice, including regulatory information
Casey M. Kepczynski, Jaelin A. Genigeski, Renee R. Koski, et al.
Journal of the American Pharmacists Association (2021) Vol. 61, Iss. 6, pp. 666-677.e2
Open Access | Times Cited: 16
SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses
Nitin K. Saksena, Srinivasa Bonam Reddy, Monica Miranda‐Saksena, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 8, pp. 166836-166836
Open Access | Times Cited: 6
Prediction of SARS-CoV-2 Variant Lineages Using the S1-Encoding Region Sequence Obtained by PacBio Single-Molecule Real-Time Sequencing
Sébastien Lhomme, Justine Latour, Nicolas Jeanne, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2544-2544
Open Access | Times Cited: 14
Whole‐genome sequencing of SARS‐CoV‐2: Comparison of target capture and amplicon single molecule real‐time sequencing protocols
Florence Nicot, Pauline Trémeaux, Justine Latour, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 10
SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron
Matthew T. Laurie, Jamin Liu, Sara Sunshine, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 12
Replacement of SARS-CoV-2 strains with variants carrying N501Y and L452R mutations in Japan: an epidemiological surveillance assessment
Yusuke Kobayashi, Takeshi Arashiro, Miyako Otsuka, et al.
Western Pacific surveillance response journal (2022) Vol. 13, Iss. 3, pp. 41-50
Open Access | Times Cited: 8
Online Phylogenetics using Parsimony Produces Slightly Better Trees and is Dramatically More Efficient for Large SARS-CoV-2 Phylogenies than de novo and Maximum-Likelihood Approaches
Bryan Thornlow, Alexander Krämer, Cheng Ye, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
Methods for sequencing the pandemic: benefits of rapid or high-throughput processing
Megan Folkerts, Darrin Lemmer, Ashlyn Pfeiffer, et al.
F1000Research (2022) Vol. 10, pp. 48-48
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top